The company, which has more than $1.3 billion in cash in hand, is counting on its ability to develop and sell an updated COVID-19 vaccine next fall and is cutting costs, Kelly told investors.
However, on an NRC website last updated in December, the federal science and technology agency said it is still working on the “technology transfer” required to produce the vaccine.Article content“Novavax continues to make progress towards establishing local manufacturing capabilities in partnership with NRC/, with manufacturing of process performance qualification batches expected to begin in early 2023,” the company said.
“We’re continuing to explore options with potential collaborators on producing vaccines and other biologics at the facility on its second production line,” Christine Jodoin, the vice-president of strategic initiatives at the NRC, wrote in an email.
このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Company planning to make COVID-19 vaccine in Canada could go out of businessAn American company that signed a deal with the federal government to produce COVID-19 vaccines in Montreal is warning investors it could go out of business within the year. No shit. 😂 😂😂😂😂😂😂🙌🏼🙌🏼🙌🏼🙌🏼🙌🏼🙌🏼👏🏼👏🏼👏🏼👏🏼 👌
ソース: CP24 - 🏆 30. / 67 続きを読む »
Canadian-founded company develops first AI-designed COVID-19 drug, starts clinical trialsFor the first time ever, a drug for COVID-19 designed with artificial intelligence is headed to clinical trials. Insilico Medicine, a Hong Kong-based AI pharmaceutical company, announced last Thursday its ISM3312 therapeutic would be starting clinical trials in China after its preclinical studies found that the drug 'significantly reduces' viral load and inflammation in the lungs. Do they know it's not 2021? Because that’s a good idea… Now make everyone stick it in their arm. That would be just fantastic.
ソース: CTVNews - 🏆 1. / 99 続きを読む »
U.S. company that made deal to produce COVID vaccine in Canada warns it could go out of businessNovavax executives told investors that there is uncertainty surrounding the company\u0027s ability to fund operations as the COVID\u002D19 vaccine market changes Just looking for a handout Ok, bye. StoptheShotsNow
ソース: nationalpost - 🏆 10. / 80 続きを読む »